Participants:18–64 years · 65+ years
Substances:1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Investigational

Czechia

Participants:18–64 years · 65+ years

Contact Research Centre

Primary biliary cholangitis

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Bezafibrate

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Crohn's disease

Not recruiting

Registered drug

Study on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Bi 706321

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Investigational

Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

Investigational

Czechia

Participants:18–64 years

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Etrasimod Arginine

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Tamuzimod Acetate

Contact Research Centre

Colitis ulcerative

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Etrasimod Arginine

Contact Research Centre

Find therapies in clinical trials near you – page 14

190 trials match your criteria

Chronic graft versus host disease

Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

Hormone-refractory prostate cancer

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Chronic rhinosinusitis with nasal polyps

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Parkinson's disease

Study of CVN424 for Reducing Motor Complications in Parkinson's Disease Patients

Crohn's disease

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Primary biliary cholangitis

Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

Colitis ulcerative

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Crohn's disease

Study on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease

Relapsing multiple sclerosis

Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

Crohn's disease

Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease

Colitis ulcerative

Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

Colitis ulcerative

Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.